10X Fund, 10% Owner of Galectin Therapeutics GALT, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $2.4M. The latest trade was on 25/12/16.

1F

1F

10X Fund

10% Owner

Company

Galectin Therapeutics GALT

First filing

25/11/12

Trades

9 trades

Buys / sales

0 / 8

12-month net buying

−$2.4M

Last trade

25/12/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Galectin TherapeuticsGALT	Open-market sale	25/12/16	25/12/18	30,681 sh	$6.66	$204,335.46	−0.5%
Galectin TherapeuticsGALT	Open-market saleAmendment	25/12/02–25/12/03	25/12/08	162,069 sh2 trades	$5.68avg.	$920,855.37	−2.8%
Galectin TherapeuticsGALT	Open-market sale	25/12/02–25/12/03	25/12/04	150,000 sh2 trades	$5.68avg.	$851,700	−2.6%
Galectin TherapeuticsGALT	Open-market sale	25/11/11	25/11/12	40,000 sh	$5.25	$210,000	−0.7%
Galectin TherapeuticsGALT	Open-market sale	25/10/22	25/10/24	50,000 sh2 trades	$4.94avg.	$246,800	−0.8%